Drug Shortage Report for VIVOTIF

Last updated on 2022-03-25 History
Report ID 127503
Drug Identification Number 00885975
Brand name VIVOTIF
Common or Proper name TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A
Company Name EMERGENT TRAVEL HEALTH INC.
Market Status MARKETED
Active Ingredient(s) TYPHOID VACCINE
Strength(s) 10B
Dosage form(s) CAPSULE (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 4 enteric-coated capsules per blister
ATC code J07AP
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-06-30
Estimated end date 2022-03-22
Actual end date 2022-03-24
Shortage status Resolved
Updated date 2022-03-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 555 TWIN DOLPHIN DRIVE
REDWOOD CITY, CALIFORNIA
UNITED STATES 94065
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-03-25 English Compare
v13 2022-03-18 French Compare
v12 2022-03-18 English Compare
v11 2022-03-10 French Compare
v10 2022-03-10 English Compare
v9 2021-07-01 English Compare
v8 2020-11-02 French Compare
v7 2020-11-02 English Compare
v6 2020-11-02 French Compare
v5 2020-11-02 English Compare
v4 2020-11-02 English Compare
v3 2020-11-02 French Compare
v2 2020-11-02 English Compare
v1 2020-10-29 English Compare

Showing 1 to 14 of 14